Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil

NCT05959720 · clinicaltrials.gov ↗

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoid Leukemia
Minimal Residual Disease
Gene Abnormality
Chemotherapeutic Toxicity

Interventions

DRUG: Prednisone
DRUG: Vincristin
DRUG: Daunorubicin
DRUG: Peg-asparaginase
DRUG: Intrathecal Suspension
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Doxorubicin

Sponsor

Instituto do Cancer do Estado de São Paulo

Collaborators

[object Object]